Dr. Mohamad Walid Ballourah

Pediatric Hematology & Oncology Department
Comprehensive Cancer Center

Current Position
Consultant, Pediatric Hematology – Oncology
General Details
Gender:
Male
Languages Spoken:
Arabic & English

Education & Board Certificates
1.       Doctor of Medicine Diploma – Damascus School of Medicine, Syria
2.       General Pediatric Residency – American University of Beirut Medical Center, Lebanon
3.       Fellowship – Pediatric Hem/Onc. American University of Beirut Medical Center, Lebanon
4.       Fellowship – Pediatric Hem/Onc. Children’s Cancer Center of Lebanon, Affiliated to St. Jude Children’s Research Hospital, Memphis, TN. USA
5.       Fellowship – Pediatric Hem/Onc. The Hospital for Sick Children- Toronto-Canada
6.       Fellowship Pediatric BMT - The Hospital for Sick Children- Toronto-Canada
7.       Certified in Patient Safety and Quality Improvement. University of Toronto – Toronto- Canada
Expertise or Specialty
Pediatric Hematology – Oncology

Research & Publications
1.       Survival Benefit for Pediatric Patients With Recurrent Ependymoma Treated with Reirradiation. International Journal of Radiation Oncology. 2012. Jan 13
2.       Venous sinus thrombosis leading to stroke in a patient with sickle cell disease on hydroxyurea and high hemoglobin levels: Treatment with thrombolysis. American Journal of Hematology, Aug 1-2008.
3.       Clinical characteristics and outcome of childhood de novo acute myeloid leukemia in Saudi Arabia: A multicenter SAPHOS leukemia group study. Leukemia Research. 49 –(2016 ) 62-72
4.       Pediatric Non-Hodgkin Lymphoma: A Retrospective 7-Year Experience in Children & Adolescents with Non-Hodgkin Lymphoma Treated at King Fahad Medical City (KFMC). Journal of Cancer Therapy, 2015, 6, 299-314
5.       Neuroblastoma in Saudi Children: A Single Center Experience (2006-2014) Journal of Cancer Therapy, 2015, 6, 896-905
6.       Survival benefit with re-irradiation for Recurrent Intracranial Ependymoma in Children. The Hospital for Sick Children, Toronto, ON, Canada. Oral presentation at the 14th International Symposium on Pediatric Neuro-Oncology – ISPNO, June 20 – 23, 2010, Vienna, Austria
7.       Dural Venous Sinus Thrombosis Causing Stroke in a Patient with Sickle Cell Disease on Hydroxyurea. Poster in The 35th Anniversary Convention of the National Sickle Cell Disease Program and the Sickle Cell Disease Association America, Inc. Septemper17-22, 2007; Washington, D.C.
8.       Childhood Cancer is a Curable Disease: Article in English and in Arabic, Newsletter of the Syrian Childhood Cancer Support Association (BASMA).Version 2, P (4-5). July-2007. URL:http://www.basma-syria.org/index.php?option=com_content&task=view&id=34&Itemid=33&lang=en

​